Corient IA’s GSK GSK Stock Holding History

Corient IA’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$104K	Sell	1,980 -3,990	-67%	-$211K	0.1%	221
2026 Q1	$329K	Hold	5,970	–	–	0.31%	121
2025 Q4	$293K	Sell	5,970 -4,030	-40%	-$188K	0.28%	154
2025 Q3	$432K	Sell	10,000 -5,000	-33%	-$195K	0.32%	122
2025 Q2	$576K	Hold	15,000	–	–	0.34%	96
2025 Q1	$581K	Buy	+15,000	New	+$549K	0.41%	79

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Corient IA's GSK Position: Q2 2026 in Review

Corient IA reduced its GSK (GSK) stake by 67% in Q2 2026, selling an estimated $211K and leaving 1,980 shares worth $104K. The position accounts for 0.1% of the portfolio, ranked #221.

Corient IA first reported a position in GSK in Q1 2025 and has held it in 6 quarters since. The position peaked at $581K in Q1 2025. 1,040 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Corient IA held 1,980 shares of GSK worth $104K as of Q2 2026.
Corient IA sold 3,990 GSK shares in Q2 2026, an estimated $211K.
GSK made up 0.1% of Corient IA's portfolio in Q2 2026, its #221 holding.
Corient IA first reported a position in GSK in Q1 2025 and has held it in 6 quarters since.
Corient IA's GSK position peaked at $581K in Q1 2025.
1,040 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Corient IA's 13F filing for Q2 2026, filed 12 Aug 2026.